Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-01-28 @ 5:10 PM
Study NCT ID:
NCT01294618
Status:
COMPLETED
Last Update Posted:
2019-05-28
First Post:
2011-02-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nilotinib + Pegylated Interferon Alpha 2a for Untreated Chronic Phase Chronic Myelogenous Leukemia
Sponsor:
Hospices Civils de Lyon
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Myelogenous Leukemia | View |